Current concepts in disorders of sexual development

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 3, Issue 3, 2011, Pages 105-114

  Öçal, Gönül ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Gender assignment; Gonads; Sex development disorders

Indexed keywords

STEROIDOGENIC FACTOR 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WILMS TUMOR SUPPRESSOR PROTEIN 1; WNT4 PROTEIN;

FEMINIZATION; GENDER IDENTITY; GENE EXPRESSION REGULATION; GONAD DEVELOPMENT; GONADAL DYSGENESIS; HUMAN; INTRACELLULAR SIGNALING; KARYOTYPE 46,XX; KARYOTYPE 46,XY; NOMENCLATURE; OVARY DEVELOPMENT; REVIEW; SEX CHROMOSOME ABERRATION; SEX DETERMINATION; SEX DIFFERENTIATION; SEX DIFFERENTIATION DISORDER; SEX REASSIGNMENT; TESTIS DEVELOPMENT; TRANSCRIPTION INITIATION; UROLOGIC SURGERY; VIRILIZATION;

ANIMALS; DISORDERS OF SEX DEVELOPMENT; FEMALE; GENITALIA; HUMANS; INFANT, NEWBORN; MALE; SEX DETERMINATION ANALYSIS;

EID: 80052910861     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.v3i3.22     Document Type: Review

References (73)

1. Allen L. Disorders of sexual development. Obstet Gynecol Clin North Am 2009;36:25-45.
2. Dreger AD, Chase C, Sausa A, Gruppusa A, Frader J. Changing nomenclature/ Toxonomy for intersex, scientific and clinical rationale J Pediatr Endocrinol Metab 2005;18:729-733.
3. Lee PA, Houk CP, Ahmet F, Hughes IA, and in collaboration with participants in the international consensus conference on intersex organized by the Lawson Wilkinns Pediatric Endocrine Society and the European Society for Pediatric Endocrinology. Consensus statement on management of intersex disorders. Pediatrics 2006;118:488-500.
4. Hughes IA. Disorders of sexual differentiation. Horm Res 2007;67(suppl1):91-95.
5. Houk CP, Lee PA. Consensus statement on terminology and management: Disorders of sex development. Sex Dev 2008;2:172-180.
6. Damian D, Paulo S. Disorder of sexual development: Still a big challenge. J Pediatr Endocrinol Metab 2007;20:749-50.
7. Carillo AA, Damian M, Bercovitz G. Disorders of sexual differentiation. From Pediatric Endocrinology Fifth ed. Ed by Lifshitz F. London. Informa Health Care 2007;2:365-413.
8. Hughes IA. Testes: Disorders of sexual differantiation and puberty in male. From Texbook Pediatric Endocrinology. Third edition. Ed by Sperling MA. Saunders comp. Pittsburg 2008. pp. 662-685.
9. Arboleda VA, Flaming AA and Vilain E. Disorders of sex development from texbook of Genetic Diagnosis of Endocrine Disorders. Ed by Weiss RE, and Refetoff S, Press in Elsevier. London 2010. pp. 227-243.
10. MacLaughlin DT, Donahoe PK. Sex determination and differentiation. N Engl J Med 2004;350:367-378.
11. Biason-Lauber A. Control of sex development. Best Pract Res Endocrinol Metab 2010;24:163-186.
12. Houmart B, Small C, Yang L, Naluai-Cecchinit, Cheng E, Hassold T, Griswold M. Global gene expression in human fetal testis or ovary. Biol Reproduct 2009;81:438-443.
13. Brennan J, Capel B. One tissue two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 2004;5:509-521.
14. Ahmed SF, Hughes A. The genetics of male undermasculinization. Clin Endocrinol 2002;56:1-10.
15. Willhelm D, and Englerd C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of SF1. Genes Dev 2002;16:1839-1851.
16. Cetinkaya E, Ocal G, Berberoglu M, Adiyaman P, Ekim M, Yalcinkaya F, Orun E. Association of partial gonadal dysgenesis, nephropathy and WT1 gene mutation without Wilm's tumor: Incomplete Denys-Drash syndrome. J Pediatr Endocrinol Metab 2001;14:561-564.
17. Biason-Lauber A, Konrad D, Meyer M, de Baufort C, Schoenle EJ. Ovaries and female phenotype in a girl with 46,XY karyotype and mutation CBX2 gene. Horm Res LSPES/ESPE 8th Joint Meeting Abstract book. New York 2009, pp. 53-54.
18. Palanco JC, Koopman P. SRY and hesistant begining of male development. Dev Biol 2007;302:13-24.
19. Sekido R, Lovel-Badge R. Sex determination and SRY: down to a wink and a nudge? Trends Genet 2009;25:19-29.
20. Morais da Silva S, Hacker A, Harley V, Goodfellow, Swain A and Lovell-Badge R. SOX9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 1996;14:62-68.
21. Hiramatsu R, Harikae K, Tsunekawa N, Kurohmaru M, Matsuo Kanai Y. FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. Development 2010:137;303-312.
22. Oakes MB, Eyvazzadeh AD, Quint E, Smith YR. Complete androgen insensitivity syndrome-a review. J Pediatr Adolesc Gynecol 2008;21:305-310.
23. Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH, Yoo HW. Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development. J Pediatr Endocrinol Metab 2008;21:545-553.
24. Yao, HH. The pathway to femaleness: current knowledge on embryonic development of the ovary. Mol Cell Endocrinol 2005;230:87-93.
25. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev 2009;30: 624-712.
26. Vainio S, Heikkil AM, Kispert A, Chin N, McMohon AP. Female development in mammals is regulated by WNT4 signalling. Nat 1999;4:405-409.
27. Biason-Lauber A.: WNT4 and R-Spontin1 signalling in ovarian development. Highlights. 46th Meeting ESPE, 2010, Praque.
28. Parma P, Radi O, Vidal V, Chaboissier MC, Dellambra E, Valentini S, Guerra L, Schedl A. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet 2006;38:1304-1309.
29. Ottolenghi C, Omari S, Garcia-Ortis JE, Uda M, Crisponi L, Foraboska A, Pilia G, Schlessinger D. FOXL2 is required for commitment to ovary differentiation. Hum Mol Genet 2005;14:205.
30. Aaronson IA. Terminology for disorders of sex development: clarity or confusion. J Urol 2011;185: 388-389.
31. Barthold JS. Disorders of sex differentiation: a pediatric urologist's perspective of new terminology and recommendations. J Urol 2011;185:393-400.
32. Wijchers PJ, Yandim C, Panousopoulou E, Ahmad M, Harker N, Saveliev A, Burgoyne PS, Festenstein R. Sexual dimorphism in mammalian autosomal gene regulation is determined not only by SRY but by sex chromosome complement as well. Dev Cell 2010;19:477-484
33. Nishi MY, Costa EM, Oliveira SB, Mendonca BB, Domenice S. The role of SRY mutations in the etiology of gonadal dysgenesis in patients with 45,X/46,XY disorder of sex development and variants. Horm Res Paediatr 2011;75;26-31.
34. Oliveira RM, Verreschi IT, Lipay MV, Eça LP, Guedes AD, Bianco B. Y chromosome in Turner syndrome: review of the literature. Sao Paulo Med J 2009;127:373-378.
35. Khandelwal A, Agarwal A, Jiloha RC. A 47,XXY female with gender identity disorder. Arch Sex Behav 2010;39:1021-1023.
36. Siklar Z, Berberoglu M, Adiyaman P, Salih M, Tukun A, Cetinkaya E, Aycan Z, Evliyaoglu O, Ergur AT, Ocal G. Disorders of gonadal development: a broad clinical, cytogenetic and histopathologic spectrum. Pediatr Endocrinol Rev 2007;4:210-217.
37. Balkan M, Akbas H, Isi H, Oral D, Turkyilmaz A, Kalkanli S, Simsek S, Fidanboy M, Alp MN, Gedik A, Budak T. Cytogenetic analysis of 4216 patients referred for suspected chromosomal abnormalities in Southeast Turkey Genet Mol Res 2010;11:1094-1103.
38. Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay's K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nuñez CJ, Servant N, Lumbroso S, Paris F CJ, Servant N, Lumbroso S, Paris F, Sultan C. Phenotypical, biological, and molecular heterogeneity of 5a-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011;96:296-307.
39. Maimoun L, Philibert P, Bouchard P, Ocal G, Leheup B, Fenichel P, Servant N, Paris F,Sultan C. Primary amenorrhea in four adolescents revealed 5a-reductase deficiency confirmed by molecular analysis. Fertil Steril 2011;95:804.
40. Ocal G, Adiyaman P, Berberoglu M, Cetinkaya E, Akar N, Uysal A, Duman T, Evliyaoglu O, Aycan Z, Lumbroso S, Sultan C. Mutation of the 5a steroid reductase type 2 gene in six unrelated patients from unrelated families and a large pedigree of an isolated Turkish village. J Pediatr Endocrinol Metab 2002;15:411-421.
41. Miller WL. P450 oxireductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestation. Trends Endocrinol Metab 2004;15:311-315.
42. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH. Congenital adrenal hyperplasia caused by mutant P450 oxireductase and human androgen synthesis: analytical studies. Lancet 2004;363:2128-2135.
43. Carani C, Simpson ER. Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 2007;3:414-421.
44. Noordam C, Dhir V, McNelis JC, Schlereth F, Hanley NA, Smeitink JA, Smeets R, Sweep FC, Claahsen-van der Grinten HL, Arlt W. Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 2009;360:2310-2318.
45. Lee PA. A perspective on the approach to the intersex child born with genital ambiquity. J Pediatr Endocrinol Metab 2004;17:133-140.
46. Brown J, and Warner G. Practical manegement of the intersex infants. J Pediatr Endocrinol Metab 2005;18:3-23.
47. Guerra-Junior G, Marciel-Guerra AT. The role of the pediatrician in the management of children with genital ambiquities. J Pediatr (Rio J) 2007;83:184-191.
48. Ouigley CA, De-Bellis A, Marschke KB, el-Awady MK, Wilso M, French FS. Androgen receptor defects. Endocr Rev 1995;16:271-321.
49. Sinnecker GH, Hiort O, Dibbelt L, Albers N, Dörr HG, et al. Phenotypic classification of male pseudohermaphroidism due to steroid 5a reductase 2 deficiency. Am J Med Genet 1996;63:223-230.
50. Prader A. Der genital befund be im pseudohermaphroditismus femininus des kongenitalen androgenitalen syndroms. Helvetica Paediatr Acta 1954;3:231-248.
51. Ocal G, Berberoglu M, Siklar Z, Bilir P, Uslu R, Yagmurlu A, Tukun A, Akar N, Soygur T, Gultan S, Toykukuk G. Disorders Sexual Development: an overviev of 18 years experience in Pediatric Endocrinology Department of Ankara University. J Pediatr Endocrinol Metab 2010;23:1123-1132.
52. Al-Agha AE, Thomset MJ, Batch JA. The child of uncertain sex: 17 years of experiance. J Pediatr Child Health 2001;37:348-351.
53. Mazen I, Hiort O, Bassiouny R, El-Gammal M. Differential diagnosis of disorders of sex development in Egypt. Horm Res 2008;70:118-123.
54. Al- Muttair A, Igbal MA, Ashwal A: Cytogenetic and etiology of ambiquous genitaliain 120 pediatric patients. Ann Sauidi Med 2004;37:348-351.
55. Zdravkovic D, Milankovic T, Sedlecki K, Guc-Scekic M, Rajic V, Banicevic M. Causes of ambiquous genitalia in neonates. Srp Arh Celok Lek 2001;129:57-60.
56. Kolon TF, Miller OF. Comparison of single versus multible dose regimens for the human chorionic gonadotropin stimulation test. J Urol 2001;166:1451-1454.
57. Simard J, Moisan AM, Michel LC, Morel Y. Males with 17ß- hydroxysteroiddehydrogenase deficiency. Endocrinologist 2003;13:195-200.
58. Grinspon RP, Rey RA. Anti-Müllerian hormone and Sertoli cell function in paediatric male hypogonodism. Horm Res 2010;73:81-92.
59. Garel L. Abnormal sex differentiation: who, how and when to image. Pediatr Radiol 2008;38(suppl3):508-511.
60. Katorza E, Pinhas-Hamail O, Mazkereth R, Gilboa Y, Achiron R. Sex differentiation disorders (SDD) prenatal sonographic diagnosis, genetic and hormonal work-up. Pediatr Endocrinol Rev 2009;7:11-21.
61. Money C. Amative orientation. The hormonal hypothesis rexemined. J Pediatr Endocrinol Metab 2002;15:951-957.
62. Houk CP, Dayner J, Lee PA. Genital ambiquity with Y choromosome: Des gender assigment matter? J Pediatr Endocrinol Metab 2004;17:825-839.
63. Ahmet SF, Morrison S, Hughes IA. Intersex and gender assignment; the third way? Arch Dis Child 2004;89:847-850.
64. Meyer-Bahlburg HFL. Gender assignment and reassignment in 46,XY pseudohermaphroditism and related condition. J Clin Endocrinol Metab 1999;84:3455-3458.
65. Reiner WG. Gender identity and sex-of-rearing in children with disorders sexual differentation. J Pediatr Endocrinol Metab 2005;18:549-553.
66. Reiner WG. Case study: Sex re-assigment in a teenage girl. Am Acad Child Adolesc Psychiatry 1996;35:799-803.
67. Birnbacher R, Marberger M, Weissenbacher G, Schober E, Frisch H. Gender identity reversal in an adolescent with mixed gonadal dysgenesis. J Pediatr Endocrinol Metab 1999;12:687-690.
68. Ocal G, Berberoglu M, Siklar Z, Bilir P. Gender dysphoria and gender change in an adolescent with 45,X/46,XY mixed gonadal dysgenesis. Exp Clin Endocrinol Diabetes 2009;117:301-304.
69. Uslu R, Oztop D, Ozcan O, Yilmaz S, Berberoglu M, Adiyaman P, Cakmak M, Kerimoglu E, Ocal G. Factors contributing to sex assignment and reassignment decisions in Turkish children with 46,XY disorders of sex development. J Pediatr Endocrinol Metab 2007;20:1001-1015.
70. de Vries AL, Doreleijers TA, Cohen-Kettenis PT. Disorders of sex development and gender identity outcome in adolescence ande adulthood: Understandig gender identity development and its clinical implications. Pediatr Endocrinol Rev 2007;4:343-351.
71. Daaboul J and Frader J. Ethics and the management of the patient with intersex: A middle way. J Pediatr Endocrinol Metab 2001;14:1575-1583.
72. Crouch NS and Creighton SM. Minimal surgical intervention in the manegement of intersex conditions. J Pediatr Endocrinol Metab 2004;17:1591-1596.
73. Vidal I, Gorduza DB, Haraux E, Gay CL, Chatelain P, Nicolino M, Mure PY, Mouriquand P. Surgical options in disorders of sex development (DSD) with ambiguous genitalia.Best Pract Res Clin Endocrinol Metab 2010;24:311-324.